Immunocytochemical Localization of Monoamine Oxidase Type B in Rat's Peripheral Nervous System

2015 ◽  
Vol 29 (11) ◽  
pp. 521-525 ◽  
Author(s):  
Qiang Chen ◽  
Yang Xu ◽  
Hui Zhang ◽  
Xiao Tan ◽  
Shu Hui Liu ◽  
...  
Keyword(s):  
Nervous System ◽  
Monoamine Oxidase ◽  
Peripheral Nervous System ◽  
Immunocytochemical Localization ◽  
Type B ◽  
Monoamine Oxidase Type B

Immunocytochemical localization of monoamine oxidase type�B in enterochromaffin-like cells of rat oxyntic mucosa

2004 ◽  
Vol 121 (3) ◽  
pp. 181-188 ◽  
Author(s):  
H. Okauchi ◽  
S. Nakajima ◽  
T. Tani ◽  
A. Ito ◽  
R. Arai
Keyword(s):  
Monoamine Oxidase ◽  
Immunocytochemical Localization ◽  
Type B ◽  
Oxyntic Mucosa ◽  
Monoamine Oxidase Type B

scholarly journals Immunocytochemical localization of monoamine oxidase type B in rat liver

10.4081/1181 ◽  
2009 ◽  
Vol 52 (1) ◽  
pp. 11 ◽  
Author(s):  
YH Huang ◽  
M Jiang ◽  
BY Fu
Keyword(s):  
Monoamine Oxidase ◽  
Rat Liver ◽  
Immunocytochemical Localization ◽  
Type B ◽  
Monoamine Oxidase Type B

scholarly journals Monoamine Oxidase Type B is Localized to Mitochondrial Outer Membranes in Mast Cells, Schwann Cells, Endothelial Cells and Fibroblasts of the Rat Tongue

2002 ◽  
Vol 35 (5) ◽  
pp. 417-422 ◽  
Author(s):  
Yang Xu ◽  
Kazusada Yoshitake ◽  
Akio Ito ◽  
Ryohachi Arai
Keyword(s):  
Endothelial Cells ◽  
Mast Cells ◽  
Monoamine Oxidase ◽  
Schwann Cells ◽  
Type B ◽  
Outer Membranes ◽  
Rat Tongue ◽  
Monoamine Oxidase Type B

(Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B

1986 ◽  
Vol 35 (2) ◽  
pp. 349-351 ◽  
Author(s):  
Ian A. McDonald ◽  
Michael G. Palfreyman ◽  
Monique Zreika ◽  
Philippe Bey
Keyword(s):  
Monoamine Oxidase ◽  
Type B ◽  
Monoamine Oxidase Type B

L-deprenyl, a selective monoamine oxidase type-b inhibitor in endogenous depression

Life Sciences ◽  
1980 ◽  
Vol 26 (11) ◽  
pp. 877-882 ◽  
Author(s):  
John Mann ◽  
Samuel Gershon
Keyword(s):  
Monoamine Oxidase ◽  
Endogenous Depression ◽  
Type B ◽  
Monoamine Oxidase Type B

scholarly journals A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease

2018 ◽  
Vol 84 (9) ◽  
pp. 1917-1927 ◽  
Author(s):  
C. D. Binde ◽  
I. F. Tvete ◽  
J. Gåsemyr ◽  
B. Natvig ◽  
M. Klemp
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Monoamine Oxidase ◽  
Meta Analysis ◽  
Type B ◽  
Multiple Treatment ◽  
Treatment Comparison ◽  
Multiple Treatment Comparison ◽  
Monoamine Oxidase Type B

scholarly journals Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis

2020 ◽  
Vol 76 (12) ◽  
pp. 1731-1743
Author(s):  
Caroline D. Binde ◽  
Ingunn F. Tvete ◽  
Jørund I. Gåsemyr ◽  
Bent Natvig ◽  
Marianne Klemp
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Monoamine Oxidase ◽  
Comparative Effectiveness ◽  
Dopamine Agonists ◽  
Relative Effectiveness ◽  
Type B ◽  
Mao B ◽  
Treatment Comparison ◽  
Monoamine Oxidase Type B

Abstract Purpose To investigate the comparative effectiveness of dopamine agonists and monoamine oxidase type-B (MAO-B) inhibitors available for treatment of Parkinson’s disease. Methods We performed a systematic literature search identifying randomized controlled trials investigating 4 dopamine agonists (cabergoline, pramipexole, ropinirole, rotigotine) and 3 MAO-B inhibitors (selegiline, rasagiline, safinamide) for Parkinson’s disease. We extracted and pooled data from included clinical trials in a joint model allowing both direct and indirect comparison of the seven drugs. We considered dopamine agonists and MAO-B inhibitors given as monotherapy or in combination with levodopa. Selected endpoints were change in the Unified Parkinson’s Disease Rating Scale (UPDRS) score, serious adverse events and withdrawals. We estimated the relative effectiveness of each dopamine agonist and MAO-B inhibitor versus comparator drug. Results Altogether, 79 publications were included in the analysis. We found all the investigated drugs to be effective compared with placebo when given as monotherapy except safinamide. When considering combination treatment, the estimated relative effects of selegiline, pramipexole, ropinirole, rotigotine, cabergoline, rasagiline and safinamide were 2.316 (1.819, 2.951), 2.091 (1.889, 2.317), 2.037 (1.804, 2.294), 1.912 (1.716, 2.129), 1.664 (1.113, 2.418), 1.584 (1.379, 1.820) and 1.179 (1.031, 1.352), respectively, compared with joint placebo and levodopa treatment. Conclusions Dopamine agonists were found to be effective as treatment for Parkinson’s disease, both when given as monotherapy and in combination with levodopa. Selegiline and rasagiline were also found to be effective for treating Parkinson’s disease, and selegiline was the best option in combination with levodopa among all the drugs investigated.

Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinson’s disease: a thorough QT/QTc study

2014 ◽  
Vol 52 (03) ◽  
pp. 192-201 ◽  
Author(s):  
Boaz Mendzelevski ◽  
Craig R. Sprenger ◽  
Ofer Spiegelstein ◽  
Laura Rabinovich-Guilatt
Keyword(s):  
Monoamine Oxidase ◽  
Type B ◽  
Cardiac Safety ◽  
Monoamine Oxidase Type B

scholarly journals Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type‐B inhibitor: A Cross‐Sectional, Cohort Study

2015 ◽  
Vol 35 (7) ◽  
pp. 681-686 ◽  
Author(s):  
Khashayar Dashtipour ◽  
Jack J. Chen ◽  
Camellia Kani ◽  
Khaled Bahjri ◽  
Mark Ghamsary
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cohort Study ◽  
Monoamine Oxidase ◽  
Clinical Outcomes ◽  
Type B ◽  
Cross Sectional ◽  
Monoamine Oxidase Type B

Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B

1985 ◽  
Vol 57 (3) ◽  
pp. 257-262 ◽  
Author(s):  
M. Da Prada ◽  
A.M. Cesura ◽  
R. Kettler ◽  
G. Zürcher ◽  
W.E. Haefely
Keyword(s):  
Monoamine Oxidase ◽  
Human Platelet ◽  
Type B ◽  
Platelet Monoamine Oxidase ◽  
Monoamine Oxidase Type B
Sign in / Sign up

Export Citation Format

Share Document